Endothelin Receptor Blockade [BQ 123] in Acute ST-elevation Myocardial Infarction.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2014
At a glance
- Drugs BQ 123 (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 03 Apr 2014 Results published in the Thrombosis and Haemostasis.
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.